<< Read Full Article
<< Read Full Article
This column originally posted on RealMoney.com at 7:01 a.m. EST. For more information about subscribing to RealMoney, please click here.
Welcome back to the Biotech Mailbag, which is overstuffed with new email now that I've moved to a twice-a-month schedule. Let's get to your questions and comments without further delay.
Readers had a lot to say about my choice of Elan's (ELN Quote) Kelly Martin as the first-ever recipient of the Nance Trophy as 2008's worst biotech CEO. Most of you were happy with the pick. I even heard nice things from the Elanians. Still, you can't please everyone. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
77.05
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |
Connect with TheStreet